Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Comment by Walterthedogon Dec 11, 2020 11:35am
64 Views
Post# 32088440

RE:FML

RE:FMLIts a bleak outlook for the sector and for THC but hope remains. Our dried flower sales should increase with the great prices and new branding but the margins will likely be nil. So just based on dried sales we should see a relatively steady or growing amount of sales with little to no margin and overall losses of 300 000 to 400 000$ per quarter. Over the course of the next year we need to get 2.0 sales to cover those losses which is a tall order but not impossible. With the available market data it looks to me like a 10 percent share in the gummy market in BC and Ont looks to be about 400 000$ wholesale and looking at other mature markets, edibles and gummies in particular are set to be the fastest growing sales category. There are 20 gummy offerings in Ot and 30 in BC so I figure if we have the cheapest product in the category and they work as well as the rest, we should easily be able to capture 10% of that market. Beverage sales are low in Canada and still a very small portion of total sales in mature markets so as cool as KISS is, I actually think that we can gain more share with gummies more than KISS. Just my thoughts. Nom nom nom, blah blah blah, release the gummy Miller and don't f1ck up production or branding! This is our last chance
<< Previous
Bullboard Posts
Next >>